ArticleClinical ophthalmology (Auckland, N.Z.)2025
Tissue Damage on Ocular Surface After Combined Phacoemulsification with Limbal Relaxing Incision Compared with Standard Phacoemulsification.
Article in Clinical ophthalmology (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To investigate the effect of phacoemulsification combined with LRIs on the ocular surface at different postoperative time. Design: This study was designed as a retrospective analysis. Medical records of patients who had undergone relevant surgeries in the past were reviewed. Patients were divided into two groups based on the surgical procedures they had received: one group was those who had undergone phacoemulsification combined with LRIs (experimental group), and the other was those who had only received phacoemulsification (control group). Methods: We retrospectively selected 80 patients (80 eyes) who had received cataract treatment. Among them, 41 eyes belonged to the experimental group and 39 eyes to the control group, which were grouped according to the degree of astigmatism as recorded in the medical files. The Tear Film Objective Scatter Index (TF-OSI), tear film break-up time (BUT), Schirmer I test, and Ocular Surface Disease Index (OSDI) scores were utilized to retrospectively evaluate the ocular surface conditions of these patients. Results: A total of 80 patients (80 eyes) were selected for phacoemulsification treatment with cataract, TF-OSI value of the experimental group was higher than that of the control group at 1 day, 1 week, 6 weeks after surgery (P < 0.05). BUT value was lower than that of the control group at 1 day, 1 week, 6 weeks after surgery (P < 0.05). Schirmer I test value was lower than that of the control group at 1 week and 6 weeks after surgery (P < 0.05). OSDI scores were higher than that of the control group 1 week, 6 weeks and 3 months after surgery (P < 0.05). Conclusion: Phacoemulsification with LRIs may cause more tissue damage on the ocular surface compared to standard phacoemulsification alone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.